FDA Inspection 1207264 — ALS Group USA, Corp

ALS Group USA, Corp — FEI 2027219

The FDA completed an inspection of ALS Group USA, Corp on Jun 5, 2023 in Torrance, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 5, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Torrance, CA (United States)

Citations

IDCFRDescription
117721 CFR 211.63Equipment Design, Size and Location

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.